Table 2.
Summarized data for alginate-based hydrogels and scaffolds applications in drug delivery systems.
| Alginate-Based Biomaterials | Applications | Reference |
|---|---|---|
| Sodium alginate, chitosan | Controlled quercetin delivery system | [50] |
| Sodium alginate, coated with chitosan and Tween 80 | Nanocarrier system for inhalation delivery of rifampicin | [51] |
| Sodium alginate, high methoxyl pectin, silver nanoparticles | Controlled ciprofloxacin delivery system | [52] |
| Sodium alginate, phthaloyl chitosan, poly(ethylene glycol) | Controlled ciprofloxacin delivery system | [53] |
| Mannose-modified alginate | Targeted antigen (ovalbumin) delivery to dendritic cells | [54] |
| Sodium alginate from brown algae, chitosan | Simultaneous and sustained release of ciprofloxacin, amoxicillin and vancomycin for individual and combined therapy | [55] |
| Sodium alginate from brown algae, methacrylic acid, 2-hydroxyethyl methacrylate, methacrylic acid and 3-[(methacryloyl amino)propyl trimethyl ammonium chloride] | Colon-targeted diclofenac sodium delivery system | [56] |
| Sodium alginate, 2-acrylamide-2-methyl propane sulfonic acid | Diclofenac sodium sustained delivery system | [57] |
| Sodium alginate, graphene oxide | Curcumin delivery system for the local treatment of squamous cell carcinoma | [58] |
| Alginate-norbornene, poly(ethylene glycol) | Stimuli-sensitive doxorubicin release system | [59] |
| Sodium alginate | Scaffolds for controlled release of daphne mucronate for wound healing application | [60] |
| Sodium alginate, gelatin, lysozyme, silica-calcium | Scaffolds for controlled release of cerium for bone tissue regeneration application | [61] |
| Sodium alginate, silk fibroin | Scaffolds for sustained and pH-sensitive release of teicoplanin and phenamil for treating chronic osteomyelitis | [62] |